Stock VILINBIO VILIN BIO MED LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Vilin Bio Med Limited

Equities

VILINBIO

INE0L4V01013

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 05:13:54 24/05/2024 pm IST 		5-day change 1st Jan Change
19 INR 0.00% Intraday chart for Vilin Bio Med Limited 0.00% -18.45%
04/05 Vilin Bio Med Limited Announces Executive Changes CI
24/02 Vilin Bio Med Limited Approves Resignation of Ashdeep Kaur from the Post of Company Secretary & Compliance Officer CI

Income Statement Evolution (Annual data)

Fiscal Period: March 2020 2021 2022 2023
Net sales 1 168.2 117.2 112.2 123.4
EBITDA 1 9.104 8.602 7.702 25.98
EBIT 1 5.988 6.032 5.508 24.3
Operating Margin 3.56% 5.15% 4.91% 19.7%
Earnings before Tax (EBT) 1 1.939 1.612 0.446 17.82
Net income 1 1.622 1.213 0.335 12.45
Net margin 0.96% 1.04% 0.3% 10.09%
EPS 2 0.1966 0.1470 0.0406 1.250
Free Cash Flow - -10.05 2.089 10.73
FCF margin - -8.58% 1.86% 8.7%
FCF Conversion (EBITDA) - - 27.12% 41.3%
FCF Conversion (Net income) - - 623.51% 86.18%
Dividend per Share - - - -
Announcement Date 30/03/23 30/03/23 30/03/23 25/08/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2020 2021 2022 2023
Net Debt 1 44.7 54.7 52.6 49
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) 4.907 x 6.358 x 6.83 x 1.885 x
Free Cash Flow - -10.1 2.09 10.7
ROE (net income / shareholders' equity) - 1.66% 0.45% 13.8%
ROA (Net income/ Total Assets) - 2.7% 2.51% 9.72%
Assets 1 - 44.88 13.36 128.1
Book Value Per Share 2 8.780 8.920 8.960 10.70
Cash Flow per Share 2 0.0800 0.0600 0.0500 0.0300
Capex 1 0.24 - - 0.3
Capex / Sales 0.14% - - 0.24%
Announcement Date 30/03/23 30/03/23 30/03/23 25/08/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
VILIN BIO MED LIMITED Stock Vilin Bio Med Limited
-18.45% 3.18M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.69% 728B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.50% 603B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.49% 360B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.24% 332B
ABBVIE INC. Stock AbbVie Inc.
+2.12% 279B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.70% 244B
NOVARTIS AG Stock Novartis AG
+7.80% 207B
ROCHE HOLDING AG Stock Roche Holding AG
-5.40% 205B
AMGEN INC. Stock Amgen Inc.
+6.42% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. VILINBIO Stock
  4. Financials Vilin Bio Med Limited